Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Botnia, case/control

The Botnia study was initiated in 1990 on the western coast of Finland in the Gulf of Bothnia with the aim to:

  1. Characterize the early metabolic defects in individuals at risk of developing type 2 diabetes
  2. Identify genetic variants predisposing to type 2 diabetes
  3. Study how the identified genetic markers and biomarkers can predict the development of type 2 diabetes and progression of the disease
  4. Identify means to prevent the development of type 2 diabetes.

A case-control sample consisting of 752 persons with type 2 diabetes and 715 healthy control participants from the Botnia study. Type 2 diabetes was diagnosed according to WHO criteria, with C-peptide concentrations ≥0.3 nmol/l, no GAD antibodies and age at onset >35 but <75 years of age. The control persons had fasting plasma glucose below 6.0 mmol/l and no first or second-degree family history of type 2 diabetes.